Life ScienceCompany
BML Pharmaceuticals Ownership
Who owns BML Pharmaceuticals?
BML Pharmaceuticals is owned by Endo International. It was acquired on July 29, 2002.
BML Pharmaceuticals Business Overview
Where is BML Pharmaceuticals headquartered?
BML Pharmaceuticals is headquartered in Manhasset, New York.
What sector is BML Pharmaceuticals in?
BML Pharmaceuticals is a life science company.
When was BML Pharmaceuticals founded?
BML Pharmaceuticals was founded in 1996.
Life Science M&A Summary in 2002
Out of 60 sectors in the Mergr database, life science ranked 12 in number of deals in 2002. The largest life science acquisition in 2002 was Immunex - which was acquired by Amgen for $16.0B.
Join Mergr to view all 36 acquisitions of life science companies in 2002, including 11 acquisitions by private equity firms, and 25 by strategics.